The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIGT.L Regulatory News (SIGT)

  • There is currently no data for SIGT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on Seneca Global Income

28 Jun 2017 08:53

RNS Number : 4018J
Seneca Global Income & Growth PLC
28 June 2017
 

 

London, UK, 28 June 2017

Edison issues review on Seneca Global Income & Growth Trust (SIGT)

Seneca Global Income & Growth Trust (SIGT) has proposed changing its benchmark to a more relevant CPI +6% versus the current Libor +3%; it aims to generate income and long-term capital growth across multiple asset classes with low volatility. SIGT also aims to grow annual dividends at least in line with UK inflation. It currently has a long-term strategic allocation to equities (60%, split 35% and 25% between UK and overseas), fixed income (15%) and specialist assets (25%, generally yielding 5-8%). SIGT has outperformed its current benchmark and the FTSE All-Share index over three and five years and since its change of mandate in 2012, with lower volatility than the UK equity market. Annual dividends have increased above the level of UK inflation for the last four years and SIGT has regularly added to reserves. The board has been actively utilising the discount control mechanism that was initiated in 2016, with the aim that SIGT's shares trade close to its NAV.

 

SIGT's shares are currently trading at a 1.4% premium to cum-income NAV; this is modestly higher than the 0.3% average premium of the last 12 months. The board has been actively utilising the discount control mechanism (DCM), repurchasing shares when they are trading at a small discount and issuing shares when they are trading on a small premium. The current premium compares to average discounts of the last three, five and 10 years of 1.9%, 4.9% and 6.7%, respectively.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Gavin Wood, +44 (0)20 3681 2503

investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALIFEDRLITFID
Date   Source Headline
18th May 20204:49 pmRNSTransaction in Own Shares
18th May 202012:24 pmRNSNet Asset Value(s)
15th May 202012:23 pmRNSNet Asset Value(s)
14th May 20204:26 pmRNSTransaction in Own Shares
14th May 202011:28 amRNSNet Asset Value(s)
13th May 20204:43 pmRNSTransaction in Own Shares
13th May 202011:36 amRNSNet Asset Value(s)
12th May 202012:02 pmRNSNet Asset Value(s)
11th May 20201:54 pmRNSNet Asset Value(s)
7th May 202011:47 amRNSNet Asset Value(s)
6th May 20204:51 pmRNSTransaction in Own Shares
6th May 202012:08 pmRNSNet Asset Value(s)
5th May 202012:27 pmRNSNet Asset Value(s)
4th May 20204:53 pmRNSTransaction in Own Shares
4th May 202012:42 pmRNSNet Asset Value(s)
1st May 20204:30 pmRNSTransaction in Own Shares
1st May 202012:40 pmRNSNet Asset Value(s)
1st May 20209:58 amRNSTotal Voting Rights
30th Apr 20204:53 pmRNSTransaction in Own Shares
30th Apr 202012:39 pmRNSNet Asset Value(s)
29th Apr 20204:46 pmRNSTransaction in Own Shares
29th Apr 202011:46 amRNSNet Asset Value(s)
28th Apr 20205:08 pmRNSTransaction in Own Shares
28th Apr 202011:49 amRNSNet Asset Value(s)
27th Apr 202011:58 amRNSNet Asset Value(s)
24th Apr 202012:18 pmRNSUpdate research from QuotedData
24th Apr 202010:33 amRNSNet Asset Value(s)
23rd Apr 202010:40 amRNSNet Asset Value(s)
22nd Apr 20205:25 pmRNSTransaction in Own Shares
22nd Apr 202012:36 pmRNSNet Asset Value(s)
21st Apr 20201:13 pmRNSNet Asset Value(s)
20th Apr 202012:10 pmRNSNet Asset Value(s)
17th Apr 20201:27 pmRNSNet Asset Value(s)
16th Apr 20201:50 pmRNSNet Asset Value(s)
15th Apr 202012:37 pmRNSNet Asset Value(s)
14th Apr 202012:54 pmRNSNet Asset Value(s)
9th Apr 20204:58 pmRNSTransaction in Own Shares
9th Apr 202011:10 amRNSNet Asset Value(s)
9th Apr 202010:11 amRNSDirector/PDMR Shareholding
8th Apr 202012:50 pmRNSNet Asset Value(s)
7th Apr 20204:55 pmRNSIssue of Equity
7th Apr 202011:18 amRNSNet Asset Value(s)
7th Apr 20207:00 amRNSDividend Declaration
6th Apr 20205:04 pmRNSTransaction in Own Shares
6th Apr 20201:05 pmRNSNet Asset Value(s)
3rd Apr 20204:51 pmRNSTransaction in Own Shares
3rd Apr 202012:15 pmRNSNet Asset Value(s)
2nd Apr 202012:07 pmRNSNet Asset Value(s)
1st Apr 202012:27 pmRNSNet Asset Value(s)
1st Apr 202011:24 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.